TRANSLATION) (a) system for the calculation of capital adequacy according to standard required by the Office, or any other higher standards approved by the Office; (b) the limit of derivatives position
the limitation of dividend payment. 10. Opinion of the Company’s Board of Directors Concerning the Transaction The Board of Directors unanimously approved the transaction due to its consideration and
Acknowledg Committee a 1.1 Ms.Pi 1.2 Mr.Su Effective fro Approved t replace the 2.1 Ms. Comm 2.2 Mr. S tion on the Directors, a nd Manager Exchange o orm for Re Audit Comm nformation M amended No ectors’ meet
Thailand 2 MD&A 2Q 2017 (Ended 30 June 2017) MASTER AD PLC MANAGEMENT DISCUSSION & ANALYSIS 2Q 2017 1 AUG 2017 IMPORTANT EVENTS IN 2Q 2017 On 16 May 2017, MACO’s Board of Directors approved the acquisition
purchase agreement and/or relevant agreements and complete the transfer of BS Myco Biotech shares on June 12, 2019. This Acquisition is considered as the assets acquisition transaction of listed company and
Company has approved the transaction. The Company hereby certifies that all information in this Information Memorandum is correct, complete, and contains all important information that shall be informed
the case where the acquisition of an asset is not approved by REIT unitholders, reasons or conditions of such declined transaction shall be specified; (4) specify details concerning disposal of each
matters: 1. Approved to dispose of the assets having the total value of not exceeding THB 14,000 million to King Power Mahanakorn Co., Ltd. which is not a connected person of the Company; therefore, it